This research offers compelling proof of a shared genetic architecture and uncovered immune interactions between MetS and sarcopenia. Our unique innovation reveals the comorbidity mechanism of metabolic syndrome and sarcopenia from a genetic perspective. The discovery of pleiotropic genes provided potential targets for intervention in MetS-related sarcopenia.